HHealth Read More Dual tumour–myeloid targeting of glioblastoma with GPNMB CAR-T cellsJuly 2, 2026 Cell lines and patient-derived GSC cultures Human GBM samples were obtained from patients who provided written informed consent…
HHealth Read More Prospective evaluation of genomics-guided off-label treatmentApril 16, 2026 Over the past nine years, DRUP provided opportunities for off-label treatment to more than 1,600 patients with advanced…
HHealth Read More Fecal microbiota transplantation plus immunotherapy in non-small cell lung cancer and melanoma: the phase 2 FMT-LUMINate trialJanuary 28, 2026 Study participants and clinical trial design The FMT-LUMINate trial (NCT04951583) is a multicenter, open-label, phase 2 trial that…
HHealth Read More A 100% effective cancer vaccine? Russia’s Enteromix achieves success in trials; Here’s the full report you need to readSeptember 8, 2025 A vaccine that could change the way we fight cancer is making headlines. Russia’s Enteromix has reportedly achieved…